MyJournals Home  

RSS FeedsEfficacy, safety, and resistance profile of osimertinib in T790M mutation-positive non-small cell lung cancer in real-world practice (PLoS ONE)

 
 

10 january 2019 11:00:14

 
Efficacy, safety, and resistance profile of osimertinib in T790M mutation-positive non-small cell lung cancer in real-world practice (PLoS ONE)
 






Del.icio.us Digg Facebook Google StumbleUpon Twitter
 
42 viewsCategory: Biology, Chemistry, General
 
Risk interval analysis of emergency room visits following colonoscopy in patients with inflammatory bowel disease (PLoS ONE)
Prognostic value of baseline metabolic tumor volume and total lesion glycolysis in patients with lymphoma: A meta-analysis (PLoS ONE)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

General

Use these buttons to bookmark us:
Del.icio.us Digg Facebook Google StumbleUpon Twitter


Valid HTML 4.01 Transitional
Copyright © 2008 - 2019 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Travel Photos Nachrichten Indigonet Finances Leer Mandarijn